Your browser doesn't support javascript.
loading
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma.
Cook, Joselle; Johnson, Isla; Higgins, Alexandra; Sidana, Surbhi; Warsame, Rahma; Gonsalves, Wilson; Gertz, Morie A; Buadi, Francis; Lacy, Martha; Kapoor, Prashant; Dispenzieri, Angela; Kourelis, Taxiarchis; Dingli, David; Fonder, Amie; Hayman, Suzanne; Hobbs, Miriam; Hwa, Yi Lisa; Kyle, Robert; Leung, Nelson; Go, Ronald; Rajkumar, Vincent S; Kumar, Shaji.
Afiliação
  • Cook J; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Johnson I; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Higgins A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Sidana S; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Warsame R; Department of Medicine, Stanford University, Stanford, California, USA.
  • Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Gertz MA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Buadi F; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lacy M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kapoor P; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kourelis T; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dingli D; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Fonder A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hayman S; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hobbs M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hwa YL; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kyle R; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Leung N; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Go R; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rajkumar VS; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kumar S; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 96(3): 330-337, 2021 03 01.
Article em En | MEDLINE | ID: mdl-33326116
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article